Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy. 1980

M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda

The comparative effectiveness of vitamin D3 and its derivatives in curing hyperparathyroidism and osteodystrophic bone lesions was examined in a laboratory model of renal osteodystrophy associated with marked secondary hyperparathyroidism in rats. The experimental model was prepared by a single injection of homologous glycopeptide. Plasma levels of 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3] appeared to decrease in the rats receiving glycopeptide. Various doses of vitamin D3 derivatives [2 or 10 microgram/kg D3, 2 microgram/kg 25-hydroxyvitamin D3 (25OHD3), 0.1 microgram/kg 1 alpha,25(OH)2D3, and 0.1 or 0.2 microgram/kg 1 alpha-hydroxyvitamin D3 (1 alpha OHD3)] were daily administered orally to the nephritic rats for 23 days before sacrifice. 1 alpha,25(OH)2D3 and 1 alpha OHD3 were much more potent than 25OHD3 and D3 in reducing the hyperplasia of parathyroir glands. The potency of 1 alpha OHD3 in curing the histological changes of osteodystrophy appeared to be greater than that of 1 alpha,25(OH)2D3. The same dose level of 1 alpha OHD3 was more effective than 1 alpha,25(OH)2D3 in enhancing plasma 1 alpha,25(OH)2D3 levels.

UI MeSH Term Description Entries
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002762 Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24. Vitamin D 3,(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol,Calciol,Cholecalciferols,Vitamin D3
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
November 1969, JAMA,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
January 1982, The Quarterly journal of medicine,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
January 1976, Journal d'urologie et de nephrologie,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
June 1978, The New England journal of medicine,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
January 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
January 1998, Expert opinion on investigational drugs,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
December 1978, Endocrinologia japonica,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
January 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
August 1978, Lancet (London, England),
M Fukushima, and R Niki, and H Ohkawa, and T Shimizu, and I Matsunaga, and H Nakano, and Y Takagaki, and Y Nishii, and K Okano, and T Suda
June 1979, Endocrinologia japonica,
Copied contents to your clipboard!